Parkinson's drug being studied

Teva Pharmaceuticals is testing its drug rasagiline mesylate for its effectiveness in treating early and advanced stage Parkinson's disease. Studies have shown that people with the disorder who take rasagiline are able to function better and demonstrate fewer symptoms of Parkinson's. Rasagiline is now expected to be submitted for regulatory approval in North America and Europe during the second half of 2003.